Skip to main content

Advertisement

SpringerLink
Log in

Mobile Health Technology in the Primary Prevention of Type 2 Diabetes: a Systematic Review

  • Diabetes Epidemiology (HC YEH Section Editor)
  • Published:
Current Diabetes Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

The objective of this review was to summarize the current scientific evidence of mobile health technology in the primary prevention of type 2 diabetes in patients with prediabetes derived from randomized clinical trials.

Recent Findings

Few randomized clinical trials are available using mobile health technologies in the prevention of type 2 diabetes. There is heterogeneity in regard to the main study outcomes, duration of interventions, and study findings.

Summary

Inconsistent findings have been reported whether mobile health technologies are effective in reducing HbA1C levels or the incidence of type 2 diabetes in patients with prediabetes. However, results are promising that mobile health interventions may decrease body weight. Future study may consistently measure changes in glycemic indicators as well as develop elements that better address behavior changes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. International Diabetes Federation. IDF diabetes atlas. 9th ed. Brussels: International Diabetes Federation; 2019.

    Google Scholar 

  2. WHO. Global status report on noncommunicable diseases 2014. Geneva: World Health Organization; 2014.

    Google Scholar 

  3. WHO. Global health estimates: deaths by cause, age, sex and country, 2000±2012. Geneva: World Health Organization; 2014.

    Google Scholar 

  4. Pan XR, Li GW, Hu YH, Wand JX, Yang WY, An ZX, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care. 1997;20:537–44.

    Article  CAS  Google Scholar 

  5. Ramachandran A, Snehalatha C, Mary S, Mukesh B, Bhaskar AD, Vijay V, et al. The Indian diabetes prevention programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia. 2006;4:289–97.

    Article  Google Scholar 

  6. Turner RC, Cull CA, Frighi V, Holman RR. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus. Progressive requirement for multiple therapies (UKPDS 49). JAMA. 1999;281:2005–12.

    Article  CAS  Google Scholar 

  7. Tuomilehto J, Lindström J, Eriksson J, Valle TT, Hämäläinen H, Ilanne-Parikka P, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344:1343–50.

    Article  CAS  Google Scholar 

  8. Knowler WC, Barrett-Connor E, Fowler SE. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl JMed. 2002;346:393–403.

    Article  CAS  Google Scholar 

  9. Kosaka K, Noda M, Kuzuya T. Prevention of type 2 diabetes by lifestyle intervention: a Japanese trial in IGTmales. Diabetes Res Clin Pract. 2005;67:152–62.

    Article  Google Scholar 

  10. Roumen C, Corpeleijn E, Feskens EJ, Mensink M, Saris WHM, Blaak EE. Impact of 3-year lifestyle intervention on postprandial glucose metabolism: the SLIM study. Diabetes Med. 2008;25(5):597–605.

    Article  CAS  Google Scholar 

  11. Ackermann RT, Finch EA, Caffrey HM, Lipscomb ER, Hays LM, Saha C. Long-term effects of a community-based lifestyle intervention to prevent type 2 diabetes: the DEPLOY extension pilot study. Chronic Illn. 2011;7(4):279–90.

    Article  Google Scholar 

  12. Ackermann RT, Finch EA, Brizendine E, Zhou H, Marrero DG. Translating the Diabetes Prevention Program into the community. The DEPLOY Pilot Study. Am J Prev Med. 2008;35(4):357–63.

    Article  Google Scholar 

  13. Ali K, Echouffo-Tcheugui J, Williamson DF. How effective were lifestyle interventions in real-world settings that were modeled on the Diabetes Prevention Program? Health Aff (Millwood). 2012;31(1):67–75.

    Article  Google Scholar 

  14. Costa B, Barrio F, Cabré JJ, Pinol JL, Cos X, Sole C, DE-PLAN-CAT Research Group, et al. Delaying progression to type 2 diabetes among high-risk Spanish individuals is feasible in real-life primary healthcare settings using intensive lifestyle intervention. Diabetologia. 2012;55(5):1319–28.

    Article  CAS  Google Scholar 

  15. Gilis-Januszewska A, Lindström J, Tuomilehto J, Piwonska-Solska B, Topor-Madry R, Szybinski Z, et al. Sustained diabetes risk reduction after real life and primary health care setting implementation of the diabetes in Europe prevention using lifestyle, physical activity and nutritional intervention (DE-PLAN) project. BMC Public Health. 2017;17(1):198.

    Article  Google Scholar 

  16. Laatikainen T, Dunbar JA, Chapman A, Kilkkinen A, Vartiainen E, Heistaro S, et al. Prevention of type 2 diabetes by lifestyle intervention in an Australian primary health care setting: Greater Green Triangle (GGT) Diabetes Prevention Project. BMC Public Health. 2007;7:249.

    Article  Google Scholar 

  17. Nilsen V, Bakke PS, Gallefoss F. Effects of lifestyle intervention in persons at risk for type 2 diabetes mellitus - results from a randomised, controlled trial. BMC Public Health. 2011;11:893.

    Article  Google Scholar 

  18. Penn L, White M, Oldroyd J, Walker M, Alberti KG, Mathers JC. Prevention of type 2 diabetes in adults with impaired glucose tolerance: the European Diabetes Prevention RCT in Newcastle upon Tyne, UK. BMC Public Health. 2009;9:277–83.

    Article  Google Scholar 

  19. Saaristo T, Moilanen L, Korpi-Hyövälti E, Vanhala M, Salteva J, Niskanen L, et al. Lifestyle intervention for prevention of type 2 diabetes in primary health care: one-year follow-up of the Finnish National Diabetes Prevention Program (FIN-D2D). Diabetes Care. 2010;33(10):2146–51.

    Article  Google Scholar 

  20. Holtz B, Lauckner C. Diabetes management via mobile phones: a systematic review. Telemed J E Health. 2012;18:175–84.

    Article  Google Scholar 

  21. Krishna S, Boren SA. Diabetes self-management care via cell phone: a systematic review. J Diabetes Sci Technol. 2008;2:509–17.

    Article  Google Scholar 

  22. Russell-Minda E, Jutai J, Speechley M, Bradley K, Chudyk A, Petrella R. Health technologies for monitoring and managing diabetes: a systematic review. J Diabetes Sci Technol. 2009;3:1460–71.

    Article  Google Scholar 

  23. Saffari M, Ghanizadeh G, Koenig HG. Health education via mobile text messaging for glycemic control in adults with type 2 diabetes: a systematic review and meta-analysis. Prim Care Diabetes. 2014;8(4):275–85.

    Article  Google Scholar 

  24. Tao D, Or CK. Effects of self-management health information technology on glycaemic control for patients with diabetes: a meta-analysis of randomized controlled trials. J Telemed Telecare. 2013;19(3):133–43.

    Article  Google Scholar 

  25. Fortmann AL, Gallo LC, Garcia MI, Taleb M, Euyoque JA, Clark T, et al. Dulce Digital: An mhealth sms-based intervention improves glycemic control in Hispanics with type 2 diabetes. Diabetes Care. 2017. https://doi.org/10.2337/dc17-0230.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Napolitano MA, Hayes S, Russo G, Muresu D, Giordano A, Foster GD. Using avatars to model weight loss behaviors: participant attitudes and technology development. J Diabetes Sci Technol. 2013;7(4):1057–65.

    Article  Google Scholar 

  27. Williams JP, Schroeder D. Popular glucose tracking apps and use of mHealth by Latinos with diabetes: review. JMIR Mhealth Uhealth. 2015;3(3):e84.

    Article  Google Scholar 

  28. Huffman M. Health coaching: a new and exciting technique to enhance patient self-management and improve outcomes. Home Healthc Nurse. 2007;25(4):271–4.

    Article  Google Scholar 

  29. Bidargaddi N, Schrade G, Klasnja P, Licinio J, Murphy S. Designing m-Health interventions for precision mental health support. Transl Psychiatry. 2020;10:222. https://doi.org/10.1038/s41398-020-00895-2.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. https://doi.org/10.1136/bmj.n71.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Sterne JAC, Savovic J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomized trials. BMJ. 2019;366:14898. https://doi.org/10.1136/bmj.14898.

    Article  Google Scholar 

  32. Block G, Azar KM, Romanelli RJ, Block TJ, Hopkins D, Carpenter HA, et al. Diabetes prevention and weight loss with a fully automated behavioral intervention by email, web, and mobile phone: a randomized controlled trial among persons with prediabetes. J Med Internet Res. 2015;17(10):e240. https://doi.org/10.2196/jmir.4897.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Fischer HH, Fischer IP, Pereira RI, Furniss AL, Rozwadowski JM, Susan L, et al. Text Message support for weight loss in patients with prediabetes: a randomized clinical trial. Diabetes Care. 2016;39(8):1364–70. https://doi.org/10.2337/dc15-2137.

    Article  CAS  PubMed  Google Scholar 

  34. Griauzde D, Kullgren JT, Liestenfeltz B, Ansari T, Johnson EH, Fedewa A, et al. Mobile phone-based program to promote healthy behaviors among adults with prediabetes who declined participation in free diabetes prevention programs: mixed-methods pilot randomized controlled trial. JMIR Mhealth Uhealth. 2019;7(1):e11267. https://doi.org/10.2196/11267.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Nanditha A, Thomson H, Susairaj P, Srivanichakorn W, Oliver N, Godsland IF, et al. A pragmatic and scalable strategy using mobile technology to promote sustained lifestyle changes to prevent type 2 diabetes in India and the UK: a randomised controlled trial. Diabetologia. 2020;63:486–96. https://doi.org/10.1007/s00125-019-05061-y.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Ramachandran A, Snehalatha C, Ram J, Selvam S, Simon M, Nanditha A, et al. Effectiveness of mobile phone messaging in prevention of type 2 diabetes by lifestyle modification in men in India: a prospective, parallel-group, randomised controlled trial. Lancet Diabetes Endocrinol. 2013;1(3):191–8. https://doi.org/10.1016/S2213-8587(13)70067-6.

    Article  PubMed  Google Scholar 

  37. Toro-Ramos T, Michaelides A, Anton M, Karim Z, Kang-Oh L, Argyrou C, et al. Mobile delivery of the Diabetes Prevention Program in people with prediabetes: randomized controlled trial. JMIR Mhealth Uhealth. 2020;8(7):e17842. https://doi.org/10.2196/17842.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Wong CK, Fung CS, Siu SC, Lo YY, Wong KW, Fong DY, et al. A short message service (SMS) intervention to prevent diabetes in Chinese professional drivers with pre-diabetes: a pilot single-blinded randomized controlled trial. Diabetes Res Clin Pract. 2013;102(3):158–66. https://doi.org/10.1016/j.diabres.2013.10.002.

    Article  PubMed  Google Scholar 

  39. The world ban. Mobile cellular subscriptions. https://data.worldbank.org/indicator/IT.CEL.SETS. Accessed November 15, 2021.

  40. de Jongh T, Gurol-Urganci I, Vodopivec-Jamsek V, Car J, Atun R. Mobile phone messaging for facilitating self-management of long-term illnesses. Cochrane Database Syst Rev. 2012;12:2012.

    Google Scholar 

  41. Cole-Lewis H, Kershaw T. Text messaging as a tool for behavior change in disease prevention and management. Epidemiol Rev. 2010;32:56–69.

    Article  Google Scholar 

Download references

Acknowledgements

The SANENT group consists of following researchers:

MARIA, L., ARELLANO FLORES; Mexico

MERCEDES, E., LEDESMA MUÑOZ; Mexico

DIANA, A., GONZÁLEZ SOTELO; Mexico

OSCAR, M., DAVILA MALDONADO; Mexico

JHOANA, G., GOMEZ GARCIA; Mexico

FRANCISCO, J., LAUREANO HERNANDEZ; Mexico

JULIO EDUARDO ZARAZUA JIMENEZ; Mexico

BRENDA, A., PULIDO GARCIA; Mexico

HECTOR, RODRIGUEZ VAZQUEZ; Mexico

ALEXIS, A., RAMIREZ DORANTES; Mexico

LILIANA, A., GONZALEZ FIERRO; Mexico

JUAN, C., HERNANDEZ HERNANDEZ; Mexico

JORGE, ZENIL PEREZ; Mexico

Funding

This study was funded by Eli Lilly and Company.

Author information

Authors and Affiliations

  1. Department of Health Policy and Management, Robert Stempel College of Public Health and Social Work, Florida International University, Miami, FL, USA

    Noël C. Barengo

  2. Division of Medical and Population Health Sciences Education and Research, Department of Translational Medicine, Herbert Wertheim College of Medicine, Florida International University, Miami, FL, USA

    Noël C. Barengo

  3. Facultad Nacional de Salud Pública, Grupo de Epidemiología, Universidad de Antioquia, Medellín, Colombia

    Paula A. Diaz Valencia

  4. Unidad de Investigación Médica en Enfermedades Endocrinas, Instituto Mexicano del Seguro Social, Ciudad de México, México

    Leticia Manuel Apolina & José E. Fernández Garate

  5. Consejo de Salubridad General, Ciudad de México, México

    Norma A. Estrada Cruz, Roberto A. Correa González, Cecilia Alicia Cinco Gonzalez, José Alberto Gómez Rodriguez & Nelly Cisneros González

Authors
  1. Noël C. Barengo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Paula A. Diaz Valencia
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Leticia Manuel Apolina
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Norma A. Estrada Cruz
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. José E. Fernández Garate
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Roberto A. Correa González
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Cecilia Alicia Cinco Gonzalez
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. José Alberto Gómez Rodriguez
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Nelly Cisneros González
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

On behalf of the SANENT Study Group

  • Maria L. Arellano Flores
  • , Mercedes E. Ledesma Muñoz
  • , Diana A. González Sotelo
  • , Oscar M. Davila Maldonado
  • , Jhoana G. Gomez Garcia
  • , Francisco J. Laureano Hernandez
  • , Julio Eduardo Zarazua Jimenez
  • , Brenda A. Pulido Garcia
  • , Hector Rodriguez Vazquez
  • , Alexis A. Ramirez Dorantes
  • , Liliana A. Gonzalez Fierro
  • , Juan C. Hernandez Hernandez
  •  & Jorge Zenil Perez

Corresponding author

Correspondence to Noël C. Barengo.

Ethics declarations

Conflict of Interest

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Noël C Barengo and Paula A Diaz Valencia are the co-first authors.

This article is part of the Topical Collection on Diabetes Epidemiology

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Barengo, N.C., Diaz Valencia, P.A., Apolina, L.M. et al. Mobile Health Technology in the Primary Prevention of Type 2 Diabetes: a Systematic Review. Curr Diab Rep 22, 1–10 (2022). https://doi.org/10.1007/s11892-021-01445-w

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11892-021-01445-w

Keywords

Search

Navigation